← All stocks

Vuzix Corp

VUZI Mostly scheduled
CIK 0001463972 #3757 in the set updated 17 Sep 2026
Bought (120 mo)
$860.11K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$57.35M
$0.00 on a plan · $57.10M straight out of an exercise
Sold at will
$256.11K
4 of 7 sales
Net
−$56.49M
+$604.00K against sales at will

By person

15 insiders · 74 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
INTEL CORP entity
10% owner
$57.10M (3) scheduled
−$57.10M
0
0.0000%
$0.00
Travers Paul J
President and CEO
$234.23K (28)
+$234.23K
2,859,670
3.39%
$13.39M
+12.1%
Kay Edward William Jr.
Director
$192.08K (8)
+$192.08K
309,511
0.3667%
$1.45M
+1,448%
Boris Paul A
COO
$151.87K (6)
+$151.87K
290,500
0.3441%
$1.36M
+81.6%
Whitten-Doolin Paula Beck
Director
$149.82K (1)
−$149.82K
120,080
0.1423%
$562.21K
Russell Grant
CFO
$85.57K (7)
+$85.57K
1,169,205
1.39%
$5.47M
+23.2%
Rajgopal Raj
Director
$76.30K (4)
+$76.30K
63,093
0.0747%
$295.40K
Harned Timothy Heydenreich
Director
$110.21K (13)
$47.30K (1)
+$62.91K
347,570
0.4117%
$1.63M
Parkinson Christopher Iain
Former officer
$58.98K (2)
−$58.98K
131,130
0.1553%
$613.95K
+5,728%
Jameson Peter Hamilton
Chief Operating Officer
$9.85K (1)
+$9.85K
164,575
0.1950%
$770.54K
RUCKDAESCHEL ALEXANDER
Director
130,147
0.1542%
$609.35K
+189.2%
MacKinnon Alasdair John
Director
94,707
0.1122%
$443.42K
SCOTT MICHAEL DENNIS
Director
60,000
0.0711%
$280.92K
+33.3%
Green Emily Nagle
Director
51,828
0.0614%
$242.66K
Arvani Azita
Director
51,828
0.0614%
$242.66K
Insider
Date
Role
Action
Shares
Price
Amount
Whitten-Doolin Paula Beck
26 May 2026
Director
Sell
32,000
$4.68
$149.82K
Harned Timothy Heydenreich
21 May 2026
Director
Sell
10,000
$4.73
$47.30K
Parkinson Christopher Iain
4 Mar 2026
See remarks
Sell
11,663
$2.69
$31.37K
Parkinson Christopher Iain
22 Dec 2025
See Remarks
Sell
9,457
$2.92
$27.61K

What was left out

Form 4 filings counted 132
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 6,927,912
History held since 20 Jan 2017